07 August 2025
: Case report 
Chemotherapy without Blood Products for Treatment of Acute Myelogenous Leukemia in an Anemic Jehovah’s Witness Patient
Unusual clinical course, Unusual setting of medical care, Clinical situation which can not be reproduced for ethical reasons
Rida Altaf ABCDE 1, Mousa Thalji EF 2, Sarah Crowder BDE 1, Kiera Brigh Turner BEF 1, Hatem Hassanein CE 2, Stephen Carlan CEF 3*DOI: 10.12659/AJCR.949145
Am J Case Rep 2025; 26:e949145
Table 3 Blood parameters during active chemotherapy.
| Day | Hemoglobin (g/dL) | White blood cells (cells/μL) | Platelets |
|---|---|---|---|
| 1 | 6.7 | 4.6 | 172×10 |
| 2 | 6.8 | 3.5 | 158×10 |
| 5 | 5.9 | 2.9 | 125×10 |
| 7 | 5.9 | 3.5 | 107×10 |
| 9 | 5.7 | 2.5 | 86×10 |
| 12 | 4.9 | 2.8 | 46×10 |
| 14 | 3.9 | 1.7 | 27×10 |
| 19 | 3.7 | 0.9 | 101×10 |
| 26 | 4.5 | 1 | 195×10 |
| 28 | 4.6 | 1.7 | 343×10 |
| 29 | 4.7 | 1.3 | 429×10 |
| 30 | 4.2 | 1.7 | 474×10 |
| 31 | 5.0 | 2.0 | 272×10 |